Extendicare Inc. (“Extendicare”) (TSX: EXE.TO) announced today that
it has entered into agreements with Revera Inc. and its affiliates
(“Revera”) and Axium Infrastructure Inc. and its affiliates
(“Axium”) , a Canadian investment firm with a strong and enduring
commitment to long-term care, in respect of the ownership,
operation and redevelopment of long-term care homes in Ontario and
Manitoba.
Highlights of the
Transactions
- Adds 56
long-term care homes to double the Extendicare Assist portfolio of
managed homes
- Revera’s
long-term care operations team to join Extendicare to advance the
delivery of high-quality care and services across all of our
homes
- Extendicare to
acquire Revera’s 15% interest in a portfolio of 24 long-term care
homes owned in partnership with Axium, and an opportunity to
purchase future Revera redevelopment projects
- Extendicare to
form a joint venture with Axium for the redevelopment of “class C”
homes owned by Extendicare
These transactions, combined with the recent
announcement of the sale of Extendicare’s Esprit retirement
communities portfolio, represent a significant transition of
Extendicare’s strategy to focus on long-term care and home health
care using a less capital-intensive business model. Extendicare
will focus its growth on operating and building new long-term care
homes, while substantially reducing the amount of its own capital
required to redevelop its “class C” portfolio. This will allow
Extendicare to deploy capital more efficiently and provide greater
flexibility for growth initiatives, including acquisitions.
Transactions Overview
Extendicare has entered into agreements with
Revera to acquire a 15% managed interest in 18 “class A” long-term
care homes located in Ontario and six homes in Manitoba (the
“Acquisition”). The remaining 85% interest will continue to be
owned by an affiliate of Axium. Relatedly, on closing of the
Acquisition, Extendicare will enter into management contracts with
Revera to manage all of Revera’s other long-term care homes, which
comprise 31 “class C” homes located in Ontario and one personal
care home located in Manitoba. Extendicare will also enter into
development arrangement agreements with Revera in respect of the
potential redevelopment of those managed “class C” homes in Ontario
into new homes (collectively with the Acquisition, the “Revera
Transactions”).
In addition to the Revera Transactions,
Extendicare announced today that it has entered into an agreement
with Axium in respect of the formation of a joint venture with
Axium to jointly redevelop certain of Extendicare’s existing
Ontario “class C” homes (the “Axium Transaction” and, with the
Revera Transactions, the “Transactions”). Axium will own an 85%
interest in the joint venture with Extendicare retaining a 15%
interest. Extendicare will continue to undertake all development
activities in respect of the joint venture homes and will operate
the homes upon completion of construction.
The Revera transactions will add 56 long-term
care homes to the 108 long-term care homes Extendicare currently
operates (58 owned, 50 managed). These homes will also join the SGP
Purchasing Partner Network, bringing the total participating beds
to over 100,000. Revera’s deeply experienced team of long-term care
experts will join Extendicare’s, in a shared mission to provide
best-in-class seniors’ care. Extendicare also has a right of first
offer on Revera’s redevelopment projects in respect of its 31 class
C homes in Ontario, either alone or in partnership with Axium.
Closing of the Revera Transactions is subject to
customary closing conditions, including receipt of regulatory
approvals from the Ontario Ministry of Long-Term Care and Manitoba
Health and Winnipeg Regional Health Authority, and is not
conditional on financing or due diligence.
The aggregate cash consideration for the Revera
Transactions is approximately $36.0 million plus the assumption of
approximately $34.0 million in debt (at Extendicare’s share),
subject to customary adjustments. Certain of the associated debt
will be refinanced or repaid on or before closing, resulting in
changes in the allocation between cash consideration and debt
assumption. The purchase price is expected to be funded from cash
on hand.
“Today’s announcement, together with the
recently announced sale of our Esprit retirement business,
represents a significant repositioning of Extendicare to focus on
growth in our long-term care and home health care segments. The
addition of the Revera long-term care team and the 56 homes to our
management portfolio meaningfully enhances our expertise and scale
to drive improved performance and high-quality care for seniors
across Canada,” said President and CEO, Dr. Michael Guerriere. “We
look forward to the opportunity to work with Revera and Axium to
rebuild as many of Revera’s 31 class C homes as approvals and
favourable market conditions permit.”
Closing of the Axium Transaction is subject to
customary closing conditions, including receipt of regulatory
approvals from the Ontario Ministry of Long-Term Care, and is not
conditional on financing or due diligence.
“Our joint venture with Axium will provide us
with access to additional capital from a Canadian infrastructure
investor with a long track record of supporting the expansion of
long-term care across the country,” said Dr. Guerriere. “There is a
pressing need to replace aging infrastructure and expand long-term
care capacity to address the growing demand for seniors’ care. This
partnership will support the redevelopment of the Extendicare class
C portfolio and give us greater financial flexibility as we
evaluate new builds and acquisitions.”
The Revera Transactions
Upon closing of the Acquisition, Extendicare
will own a 15% interest in the 24 long-term care homes currently
jointly owned by Revera and Axium and will operate the homes in
consideration for a customary management fee. These homes consist
of approximately 3,000 funded long-term care beds.
"We will work closely with Revera to ensure that
residents, their families and staff at these homes experience a
smooth transition to Extendicare’s operations,” said Dr. Guerriere.
“There will be no job losses as a result of today’s announcement.
Our collective long-term care teams have deep experience in caring
for seniors, and we need everyone as we work to improve care for
the residents we serve today and the seniors who will need care
tomorrow.”
As part of the Acquisition, Extendicare will
assume management of Revera’s remaining long-term care homes, which
comprise 31 “class C” homes located in Ontario and one personal
care home located in Manitoba, and will offer employment to
Revera’s head office long-term care personnel. These homes consist
of approximately 3,700 funded long-term care beds and 760 private
pay assisted living beds. The management agreements are on
customary terms for agreements of this type.
The Revera Transactions are expected to generate
approximately $17.0 million in additional annual revenue in our
Other Operations segment related to the services provided to the
additional 56 homes.
Consistent with Extendicare’s stated commitment
to redevelop “class C” homes to further the availability of best in
class long-term care homes for Ontario’s seniors, as part of the
Revera Transactions, Revera and Extendicare will enter into
development arrangement agreements pursuant to which Revera will
grant Extendicare (either alone or with Axium) a right to
participate in any redevelopment of Revera’s Ontario “class C”
homes should Revera determine to pursue redevelopment of any of
those homes into new long-term care homes. If Extendicare
determines, in its discretion, to participate in any such
redevelopment project, Revera will act as development and
construction manager and will be paid customary development and
construction management fees. Upon completion of any approved
redevelopment project, the home would be acquired by Extendicare
(either alone or with Axium) and Extendicare would operate the
homes on the same terms as it will operate the homes to be acquired
in the Acquisition. There are currently four “class C” homes
comprising an aggregate of approximately 700 funded long-term care
beds that are in advanced stages of redevelopment, one of which is
currently under construction, that Extendicare expects it will
participate in along with Axium, subject to customary conditions.
However, no assurance can be given as to whether those projects, or
any other redevelopment projects, will ultimately proceed or be
acquired by Extendicare.
The Axium Transaction
Upon closing of the Axium Transaction, Axium
will acquire an 85% interest in the joint venture, with Extendicare
retaining a 15% managed interest. Extendicare will continue to
undertake all development activities in respect of the joint
venture homes and will operate the homes upon completion of
construction. As part of the Axium Transaction, Extendicare and
Axium have entered into a master development agreement pursuant to
which Extendicare has granted Axium a right to participate in the
redevelopment of five of Extendicare’s Ontario “class C” homes
located in Sudbury (two homes), Kingston, Stittsville and
Peterborough, Ontario. This development arrangement could also
apply to additional redevelopment projects should Extendicare wish
to offer them to Axium. Extendicare will act as development and
construction manager and will be paid customary development and
construction management fees in respect of any projects in which
Axium participates. Upon receipt of necessary redevelopment
approvals, the home would be acquired by the Extendicare/Axium
joint venture and Extendicare would operate the homes on the same
terms as it will operate the homes to be acquired in the
Acquisition.
There are currently three “class C” homes
comprising an aggregate of 704 funded long-term care beds that are
currently under construction that Axium has agreed to participate
in, subject to customary conditions.
Advisors
BMO Capital Markets is acting as financial
advisor to Extendicare and Torys LLP is acting as legal advisor to
Extendicare in connection with the Transactions. Stikeman Elliott
LLP is acting as legal advisor to Axium in connection with the
Transactions. Stormont Partners Advisory is acting as financial
advisor to Revera and Goodmans LLP is acting as legal advisor to
Revera in connection with the Revera Transactions.
About Extendicare
Extendicare is a leading provider of care and
services for seniors across Canada, operating under the
Extendicare, Esprit Lifestyle, ParaMed, Extendicare Assist, and SGP
Purchasing Partner Network brands. We are committed to delivering
quality care throughout the health continuum to meet the needs of a
growing seniors population. We operate or provide contract services
to a network of 119 long-term care homes and retirement communities
(69 owned/50 contract services), provide approximately 9.2 million
hours of home health care services annually, and provide group
purchasing services to third parties representing approximately
93,200 senior residents across Canada.
Extendicare proudly employs more than 20,000
qualified, highly trained and dedicated team members who are
passionate about providing high-quality care and services to help
people live better.
About Axium Infrastructure
Axium Infrastructure (comprised of Axium
Infrastructure Inc. and its affiliated entities) is an independent
portfolio management firm dedicated to generating long-term
investment returns through investing in core infrastructure assets.
Axium Infrastructure had approximately C$7.9 billion in assets
under management as of September 30, 2021, as well as approximately
C$1.7 billion in co-investments. The firm benefits from the
capabilities of a group of specialists with decades of experience
acquiring, developing, financing, operating and managing
infrastructure assets. Focus is placed on assets that are supported
by robust market demand and under long-term contract with
creditworthy counterparties. Since 2010, the firm has invested in a
diversified portfolio of over 200 North American infrastructure
assets.
Forward-looking Statements
This press release contains forward-looking
statements concerning anticipated future events, results,
circumstances, economic performance or expectations with respect to
Extendicare and its subsidiaries, including, without limitation,
statements regarding the Transactions and the impact on our
business should the Transactions close. Forward-looking statements
can often be identified by the expressions “anticipate”, “believe”,
“estimate”, “expect”, “intend”, “objective”, “plan”, “project”,
“will” or other similar expressions or the negative thereof. These
forward-looking statements reflect Extendicare’s current
expectations regarding future results, performance or achievements
and are based upon information currently available to us and on
assumptions that Extendicare believes are reasonable. Extendicare
assumes no obligation to update or revise any forward-looking
statement, except as required by applicable securities laws. These
statements are not guarantees of future performance and involve
known and unknown risks, uncertainties and other factors that may
cause actual results, performance or achievements to differ
materially from those expressed or implied in the statements. For
further information on the risks, uncertainties and assumptions
that could cause Extendicare’s actual results to differ from
current expectations, refer to “Risk and Uncertainties” and
“Forward Looking-Statements” in Extendicare’s 2021 MD&A filed
by Extendicare with the securities regulatory authorities,
available at www.sedar.com and on Extendicare’s website at
www.extendicare.com. Given these risks and uncertainties, readers
are cautioned not to place undue reliance on Extendicare’s
forward-looking statements.
For further information, please
contact:Investor Inquiries:David
BaconSenior Vice President and Chief Financial OfficerEmail:
david.bacon@extendicare.comPhone: (905) 470-5587
Media Inquiries:Laura
GallantSenior Manager, External RelationsEmail:
laura.gallant@extendicare.comPhone: (416) 895-5676
Extendicare (TSX:EXE)
Historical Stock Chart
From Oct 2024 to Nov 2024
Extendicare (TSX:EXE)
Historical Stock Chart
From Nov 2023 to Nov 2024